LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Restaurants for Sale
Entertainment & Recreation Businesses for Sale
Startup Investment Opportunities
Dollar Stores for Sale
Advertising & Promotional Businesses for Sale
Automotive Businesses for Sale
Employment & Personnel Businesses for Sale
Farms & Vineyards for Sale
Manufacturing Businesses for Sale
Coffee Shop, Bakery & Dessert Businesses for Sale
Coffee, Bakery & Dessert Franchise Opportunities
Healthcare & Medical Franchise Opportunities
Technology Franchise Opportunities
Cleaning & Janitorial Franchises for Sale
Hotel & Motel Franchises for Sale
Real Estate & Property Management Franchise for Sale
Pet Franchise Opportunities
Finance & Accounting Franchise Opportunities
Fitness & Wellness Franchises for Sale
Clothing & Shoe Store Franchise Opportunities
Office Buildings for Sale or Rent
Houses & Condos for Sale or Lease
Medical Office Spaces for Sale or Rent
Medical Buildings for Sale or Lease
Miscellaneous Properties for Sale or Lease
Apartment Buildings for Sale
Industrial Units for Sale or Rent
Commercial Buildings for Sale or Lease
Land & Developments for Sale
Commercial Spaces for Sale or Lease
An email will be sent to registered email address.
Please select if you are: